Bioblast Pharma Ltd. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
270.00
32,611.00
19,332.00
9,880.00
3,526.00
Total Accounts Receivable
26.00
93.00
145.00
52.00
28.00
Other Current Assets
3.00
181.00
915.00
609.00
68.00
Total Current Assets
299.00
32,885.00
20,392.00
10,541.00
3,622.00
Net Property, Plant & Equipment
2.00
60.00
91.00
71.00
-
Total Investments and Advances
-
-
33.00
11.00
-
Other Assets
5.00
9.00
-
7.00
-
Total Assets
306.00
32,954.00
20,516.00
10,630.00
3,622.00
Accounts Payable
-
-
-
700.00
19.00
Other Current Liabilities
131.00
2,280.00
2,514.00
1,231.00
441.00
Total Current Liabilities
131.00
2,280.00
2,514.00
1,931.00
460.00
Other Liabilities
-
-
70.00
-
-
Total Liabilities
131.00
2,280.00
2,584.00
1,931.00
460.00
Common Equity (Total)
175.00
30,674.00
17,932.00
8,699.00
3,162.00
Total Shareholders' Equity
175.00
30,674.00
17,932.00
8,699.00
3,162.00
Total Equity
175.00
30,674.00
17,932.00
8,699.00
3,162.00
Liabilities & Shareholders' Equity
306.00
32,954.00
20,516.00
10,630.00
3,622.00
About Bioblast Pharma
View Profile
